Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed MyelomaBrian A. Walker, Gareth J. Morgan, Dil Begum et al.|Journal of Clinical Oncology|2015Cited by 564
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle controlCharlotte Pawlyn, Faith E. Davies|Blood Cancer Journal|2017Cited by 105
Bortezomib, Vorinostat, and Dexamethasone Combination Therapy in Relapsed Myeloma: Results of the Phase 2 MUK four TrialSarah Brown, Matthew Jenner, Charlotte Pawlyn et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 22